NCT02878226

Brief Summary

Uterine rupture (UR) is a serious, life-threatening obstetric complication. UR is associated with an increased risk of maternal and perinatal morbidity and mortality, particularly in developing countries compared to developed countries. UR occurs mainly as a consequence of poorly managed labour

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2018

Completed
Last Updated

June 27, 2018

Status Verified

June 1, 2018

Enrollment Period

1.4 years

First QC Date

August 22, 2016

Last Update Submit

June 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • number of women undergoes repair

    1 hour

Interventions

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients presented with clinical symptoms and signs of rupture uterus, whatever the duration of pregnancy, and the diagnosis proved on surgical exploration to be a case of rupture uterus

You may qualify if:

  • women with ruptured uterus
  • accept to share in the study

You may not qualify if:

  • women refuse to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Location

MeSH Terms

Conditions

Maternal Death

Condition Hierarchy (Ancestors)

Parental DeathDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

August 22, 2016

First Posted

August 25, 2016

Study Start

August 1, 2016

Primary Completion

December 15, 2017

Study Completion

February 18, 2018

Last Updated

June 27, 2018

Record last verified: 2018-06

Locations